S'abonner

Validity of self-reported nail counts in patients with onychomycosis: A retrospective pilot analysis - 24/04/13

Doi : 10.1016/j.jaad.2007.09.022 
Peter M.H. Cham, MD a, Suephy C. Chen, MD, MS b, c, d, Joseph P. Grill, MS e, Erin M. Warshaw, MD, MS a, e,
a Department of Dermatology, University of Minnesota, Minneapolis, Minnesota 
b Department of Dermatology, Emory University, Atlanta, Georgia 
c Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta, Georgia 
d Department of Health Services Research and Development, Atlanta Veterans Affairs Medical Center (VAMC), Atlanta, Georgia 
e Center for Chronic Disease Outcomes Research, Minneapolis VAMC, Minneapolis, Minnesota 

Correspondence to: Erin M. Warshaw, MD, MS, Clinical Associate Professor of Dermatology, University of Minnesota, Chief, Dermatology VAMC, Department 111K, VAMC, One Veterans Dr, Minneapolis, MN 55417.

Abstract

Background

Onychomycosis (fungal infection of the toenails or fingernails) is common, affecting up to 8% of the general population. Telephone and mailed surveys conducted to study this disease are usually completed via patient self-report. The validity of the counts of diseased nails reported by the patients participating in these surveys has not been established.

Objective

The aim of this study was to assess the interrater agreement between patient and health care professional (HCP) counts of affected nails in patients with onychomycosis.

Methods

Patient and HCP counts of infected toenails and fingernails corresponding to a total of 567 patients originating from 3 different clinical trials were retrospectively analyzed. All these patients were initially classified as mycologically positive for toenail onychomycosis, and all 3 trials used identical self-administered questions regarding counts of infected toenails and fingernails. The level of agreement between patient versus HCP counts of infected toenails and fingernails (based on collapsed and uncollapsed counts) was measured using the quadratically weighted κ statistic.

Results

Thirty-eight percent (213/554, 95% confidence interval [CI] = 35% to 43%) of the 554 patients with self-reported and HCP counts of infected toenails had exact agreement; for these 554 patients, quadratically weighted κ = 0.47 (95% CI: 0.40 to 0.54). The highest agreement rates—79, 62, and 50%—correspond to the patients with HCP counts of affected toenails equaling 1, 2, and 10, respectively; that is, HCP counts at the extremes. The agreement rates ranged from 3% to 31% for the remaining patients with HCP counts between 3 and 9. Patients tended to undercount affected toenails, irrespective of the number of affected toenails counted by HCPs. No statistically significant association was found between agreement rates and whether or not the patients had been previously treated for toenail onychomycosis (P = .91). A marginally nonsignificant association of increasing agreement rates with increasing disease duration was observed (P = .06). Among the patients who reported one or more affected fingernails (n = 122), percent agreement was similar to that of toenails (41%, 95% CI: 33.0 to 50.0%).

Limitations

This pilot study is limited by its retrospective design, its homogeneous group of patients (predominantly white, male veterans), and the fact that information on intraobserver and interobserver reliability was not obtained from all of the 3 clinical trials, the sources for this analysis.

Conclusions

Patients tend to undercount affected nails as compared to HCPs. Reliance on self-reported counts in epidemiological surveys may lead to an inaccurate, underestimate of disease severity.

Le texte complet de cet article est disponible en PDF.

Abbreviations used : CI, HCP, OR, SD, VAMC


Plan


 Supported by the Center for Chronic Disease Outcomes Research and the Minneapolis VAMC. Dr Warshaw was supported by a VA Cooperative Studies Clinical Research Career Development Award (#711B) during this study. Dr Chen was supported in part by a Mentored Patient Oriented Career Development Award (#K23AR02185-01A1) from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health.
 Conflicts of interest: None declared.
 The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs.
 Reprints not available from the authors.


© 2008  American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 58 - N° 1

P. 136-141 - janvier 2008 Retour au numéro
Article précédent Article précédent
  • Cost-effectiveness of biologic treatments for psoriasis based on subjective and objective efficacy measures assessed over a 12-week treatment period
  • Andrew A. Nelson, Daniel J. Pearce, Alan B. Fleischer, Rajesh Balkrishnan, Steven R. Feldman
| Article suivant Article suivant
  • What’s new online?

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.